The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, November 01, 2019
Rutgers has been designated as a NIH's REACH program to speed up the commercialization of biomedical discoveries into viable diagnostics.
read more
Friday, November 01, 2019
Regen BioPharma announced new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in ...
read more
Tuesday, October 22, 2019
The NIH has awarded Matthew David Taylor, MD a four-year grant to determine whether prior infections change how the body responds to sepsis.
read more
ProMIS Neurosciences continues to further develop antibody candidates that have shown selectivity for the toxic forms of tau.
read more
Wednesday, October 16, 2019
Denovo Biopharma has announced FDA's approval to initiate a Phase 2b clinical study of DB102 in patients with newly-diagnosed glioblastoma in ...
read more
The Allen Institute released its first dataset of electrical brain activity gathered using Neuropixels, a new high-resolution silicon probe that can ...
read more
The FDA has awarded 12 new clinical trial research grants totaling more than $15 million over the next four years to enhance the development of ...
read more
Tuesday, September 24, 2019
Bayer, Brigham and Women's Hospital, and Massachusetts General Hospital announced the launch of a joint lab to research new drug candidates to treat ...
read more
Tuesday, September 24, 2019
Over the past few years we’ve witnessed new medical breakthroughs that are altering how diseases are treated in ways that seemed unimaginable just a ...
read more
Thursday, September 05, 2019
ZyVersa announced advancements in development of our lead inflammasome inhibitor candidate, IC 100.
read more
Tuesday, September 03, 2019
SutroVax received an award from CARB-X to develop a universal vaccine to prevent infections caused by Group A Strep bacteria, which include ...
read more
The DSMB recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114 in what is being ...
read more
GEMoaB GmbH announced the dosing of the first patient in a Phase I open-label, dose escalation study of GEM3PSCA, an Affinity-Tailored Adapter for T-...
read more
Pharmazz has received permission to initiate a study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke...
read more
Geneos announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology.
read more